Filing Details
- Accession Number:
- 0000950170-25-074297
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-19 16:02:03
- Reporting Period:
- 2025-05-19
- Filing Date:
- 2025-05-19
- Accepted Time:
- 2025-05-19 16:02:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1395937 | Syndax Pharmaceuticals Inc | SNDX | Pharmaceutical Preparations (2834) | 320162505 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1653276 | Jr. H. Martin Huber | C/O Syndax Pharmaceuticals, Inc. 730 Third Avenue, Floor 9 New York NY 10017 | No | No | No | No |
Transaction Summary
Purchased: | 5,000 shares | Avg. Price: $8.99 | Total Value: $44,950.00 |
Number of Shares After Transactions: | 79,000 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-05-19 | 5,000 | $8.99 | 79,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |